ENTERA BIO LTD. Ttl Offering Amt
ENTERA BIO LTD. (ENTX) had Ttl Offering Amt of $389.58 million as of 2026-08-21, per its S-3 filed 2026-08-21.
Financial Statements › Notes
ffd:TtlOfferingAmt · last filed 2026-08-21
- 2026-08-21: Ttl Offering Amt $389.58M.
- 2026-08-06: Ttl Offering Amt $13.32M.
- 2026-05-03: Ttl Offering Amt $22.31M.
| Period end | Ttl Offering Amt |
|---|---|
| 2026-08-21 | $389.58M S-3 · filed 2026-08-21 |
| 2026-08-06 | $13.32M S-8 · filed 2026-08-07 |
| 2026-05-03 | $22.31M S-3 · filed 2026-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |